e-learning
resources
Berlin 2008
Sunday, 05.10.2008
The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How do patients with vascular rings/slings die?
K. O. Dubowy, D. Kececioglu, U. Blanz, S. Sarikouch (Bad Oeynhausen, Germany)
Source:
Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Session:
The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Session type:
Thematic Poster Session
Number:
1274
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. O. Dubowy, D. Kececioglu, U. Blanz, S. Sarikouch (Bad Oeynhausen, Germany). How do patients with vascular rings/slings die?. Eur Respir J 2008; 32: Suppl. 52, 1274
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
How do lung cancer patients die?
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
Do COPD patients have a pulmonary vascular phenotype?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
Do hospitalized COVID-19 patients have endothelial vascular dysfunction? A cohort study
Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment
Year: 2021
How do patients with COPD and chronic respiratory failure die and what can we do?
Source: Annual Congress 2012 - Advances in chronic respiratory failure in COPD: now out of its infancy
Year: 2012
Which severe COVID-19 patients may benefit the most from pulmonary rehabilitation?
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Year: 2021
Pulmonary function in elderly patients with diagnosis of lung cancer – an excuse for giving up surgery?
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008
How are we going to treat IPF patients in the future?
Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges
Year: 2013
What do patients with COPD need to know?
Source: Eur Respir J 2003; 22: Suppl. 45, 168s
Year: 2003
How can we stop people with COPD dying?
Source: Annual Congress 2006 - New insights into the worldwide burden of COPD
Year: 2006
Are patients with recurrent pulmonary embolism diagnosed earlier than those with their first episode? Unfortunately not!
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010
TB patients are coming back to hospital – why?
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008
Treatment of early lung disease – is it possible? Does it work?
Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early
Year: 2004
How can we better predict pulmonary blood clots in patients hospitalised for COVID-19?
Source: Eur Respir J, 56 (4) 2003092; 10.1183/13993003.03092-2020
Year: 2020
Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ?
Source: International Congress 2018 – French Programme 2018: Part II
Year: 2018
Who should treat lung cancer patients and where should they be treated?
Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients
Year: 2009
1 year evolution of COPD patients systemic endothelial dysfunction
Source: Eur Respir J 2005; 26: Suppl. 49, 718s
Year: 2005
Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
What do patients expect from ERN-LUNG?
Source: International Congress 2018 – Rare lung diseases
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept